Ligand Pharmaceuticals LGND Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.35M+68.6% | $44.78M+244% | $117.27M+1,735% | $4.85M+109% | -$42.45M-149% | ||
| $8.22M-6.3% | $8.21M-4.8% | $8.27M-8.1% | $8.52M-3.7% | $8.77M+0.1% | ||
| $10.6M+35.2% | $14.27M+89.7% | $14.75M-2.8% | $10M-9.6% | $7.84M+6.8% | ||
| $48.69M+291% | $45.92M+61.3% | $13.09M-64.2% | $15.8M+18.7% | -$25.45M-236% | ||
| $228K+6.5% | $9K-98.7% | $15K-97.5% | $214K-47.5% | $214K+104% | ||
| -$94.35M-2,028% | -$18.1M+53.1% | -$353.45M-660% | -$10.67M+80.5% | $4.89M+230% | ||
| -$14.13M-198% | $8.33M-59.1% | $409.65M+644% | $15M+58.0% | -$4.75M-139% | ||
| -$59.83M-146% | $35.55M+309% | $71.71M+57.7% | $19.68M+162% | -$24.32M-190% | ||
| $48.46M+289% | $45.91M+65.4% | $13.08M-63.6% | $15.59M+20.8% | -$25.66M-238% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ligand Pharmaceuticals generate?
- Ligand Pharmaceuticals (LGND) generated $123.5M in operating cash flow over the trailing twelve months.
- What is Ligand Pharmaceuticals's free cash flow?
- After $466.0K of capital expenditures, Ligand Pharmaceuticals's free cash flow was $123.0M over the trailing twelve months, up 141.5% year over year.
- Where does Ligand Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ligand Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
